Latest news about VivaQuant
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
VivaQuant was recognized by *Inc.* Magazine in August 2023 as one of the fastest-growing private companies in America, highlighting its innovative mobile cardiac telemetry device, the RX-1 *mini*, and its significant revenue growth and commitment to accurate and efficient cardiac arrhythmia monitoring[2].
VivaQuant introduced the RX-1 *mini*, the smallest one-piece mobile cardiac telemetry device, which continuously analyzes ECGs, identifies arrhythmias using advanced AI and signal processing, and communicates data via cellular technology. It offers high patient comfort, extended battery life, and FDA clearance, with data secured through NSA-level encryption[1][2][5].
VivaQuant Inc., doing business as Rhythm Express, debuted at No. 2 on the 2024 Fast 50 list with a growth rate of 721.94%. The company reported $11.7 million in revenue for 2023 and expanded its workforce from 5 employees in 2021 to 75. It is focusing on growing its distribution channel, enhancing cybersecurity and product quality, and developing technology to expand indications[1].
Open job positions at VivaQuant
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

